Education
About Us
Working with TipRanks
Follow Us
Surgery Partners Inc (SGRY)
NASDAQ:SGRY
Total Valuation
Surgery Partners has a market cap or net worth of $2.84B. The enterprise value is $5.21B.
Market Cap$2.84B
Enterprise Value$5.21B
Share Statistics
Surgery Partners has 128,160,080 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding128,160,080
Owned by Insiders1.39%
Owned by Institutions1.02%
Financial Efficiency
Surgery Partners’s return on equity (ROE) is -0.09 and return on invested capital (ROIC) is 0.40%.
Return on Equity (ROE)-0.09
Return on Assets (ROA)-0.02
Return on Invested Capital (ROIC)0.40%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee207.62K
Profits Per Employee833.33
Employee Count15,000
Asset Turnover0.39
Inventory Turnover26.80
Valuation Ratios
The current PE Ratio of Surgery Partners is -15.88. Surgery Partners’s PEG ratio is -9.62.
PE Ratio-15.88
PS Ratio0.00
PB Ratio1.28
Price to Fair Value1.49
Price to FCF32.76
Price to Operating Cash Flow16.13
PEG Ratio-9.62
Income Statement
In the last 12 months, Surgery Partners had revenue of 3.11B and earned -168.10M in profits. Earnings per share was -1.33.
Revenue3.11B
Gross Profit745.60M
Operating Income348.80M
Pretax Income147.10M
Net Income-168.10M
EBITDA501.40M
Earnings Per Share (EPS)-1.33
Cash Flow
In the last 12 months, operating cash flow was 265.40M and capital expenditures -92.10M, giving a free cash flow of 173.30M billion.
Operating Cash Flow265.40M
Free Cash Flow173.30M
Free Cash Flow per Share1.35
Dividends & Yields
Surgery Partners pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.35
52-Week Price Change-4.03%
50-Day Moving Average22.48
200-Day Moving Average24.50
Relative Strength Index (RSI)50.35
Average Volume (3m)1.79M
Important Dates
Surgery Partners upcoming earnings date is Aug 5, 2025, Before Open (Confirmed).
Last Earnings DateMay 12, 2025
Next Earnings DateAug 5, 2025
Ex-Dividend Date―
Financial Position
Surgery Partners as a current ratio of 1.79, with Debt / Equity ratio of 146.62%
Current Ratio1.79
Quick Ratio1.65
Debt to Market Cap1.26
Net Debt to EBITDA6.85
Interest Coverage Ratio1.73
Taxes
In the past 12 months, Surgery Partners has paid 134.60M in taxes.
Income Tax134.60M
Effective Tax Rate0.92
Enterprise Valuation
Surgery Partners EV to EBITDA ratio is 12.17, with an EV/FCF ratio of 29.11.
EV to Sales1.96
EV to EBITDA12.17
EV to Free Cash Flow29.11
EV to Operating Cash Flow20.34
Balance Sheet
Surgery Partners has $229.30M in cash and marketable securities with $3.86B in debt, giving a net cash position of $3.63B billion.
Cash & Marketable Securities$229.30M
Total Debt$3.86B
Net Cash$3.63B
Net Cash Per Share$28.36
Tangible Book Value Per Share-$12.67
Margins
Gross margin is 22.64%, with operating margin of 11.20%, and net profit margin of -5.40%.
Gross Margin22.64%
Operating Margin11.20%
Pretax Margin4.72%
Net Profit Margin-5.40%
EBITDA Margin16.10%
EBIT Margin11.20%
Analyst Forecast
The average price target for Surgery Partners is $31.22, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$31.22
Price Target Upside40.95% Upside
Analyst ConsensusModerate Buy
Analyst Count10
Revenue Growth Forecast13.54%
EPS Growth Forecast-30732.00%